Biology of papillomavirus replication in infected epithelium

Future Virology

Volumn 2, Issue 6, 2007, Pages 573-586

  Doorbar, John ^a   Raj, Kenneth ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Cervical cancer; Cervix; Differentiation; Papillomavirus; Viral replication

Indexed keywords

CELL DNA; CELL PROTEIN; CYCLINE; GLYCOPROTEIN E1; GLYCOPROTEIN E2; PROTEIN E4; PROTEIN E5; PROTEIN E6; PROTEIN E7; REPLICATION FACTOR C; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

BASAL CELL; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; DNA REPLICATION; EPITHELIUM CELL; GENE AMPLIFICATION; HUMAN; MOLECULAR MECHANICS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SKIN EPITHELIUM; VERRUCA VULGARIS; VIROGENESIS; VIRUS GENOME; VIRUS REPLICATION; VIRUS TRANSMISSION; WART VIRUS;

PAPILLOMAVIRIDAE;

EID: 36348994390     PISSN: 17460794     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460794.2.6.573     Document Type: Review

References (110)

1. Terai M, DeSalle R, Burk RD: Lack of canonical E6 and E7 open reading frames in bird papillomaviruses: Fringilla coelebs papillomavirus and Psittacus erithacus timneh papillomavirus. J. Virol. 76(19), 10020-10023(2002).
2. Tachezy R, Rector A, Havelkova M et al.: Avian papillomaviruses: the parrot Psittacus erithacus papillomavirus (PcPV) genome has a unique organization of the early protein region and is phylogenetically related to the chaffinch papillomavirus. BMC Microbiol. 2(1), 19 (2002).
3. Gottschling M, Stamatakis A, Nindl I et al.: Multiple evolutionary mechanisms drive papillomavirus diversification. Mol. Biol. Evol. 24(5), 1242-1258 (2007).
4. Peh WL, Middleton K, Christensen N et al.: Life cycle heterogeneity in animal models of human papillomavirus-associated disease. J. Virol. 76(20), 10401-10416 (2002).
5. Middleton K, Peh W, Southern S et al.: Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers. J. Virol. 77(19), 10186-10201 (2003).
6. Doorbar J: Molecular biology of human papillomavirus infection and cervical cancer Clin. Sci. (Lond) 110(5), 525-541 (2006).
7. Hebner CM, Laimins LA: Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev. Med. Virol. 16(2), 83-97 (2006).
8. Doorbar J: The papillomavirus life cycle. J. Clin. Virol. 32 (Suppl. 1), S7-S15 (2005).
9. Egawa K: Do human papillomaviruses target epidermal stem cells? Dermatology 207(3),251-254 (2003).
10. Day PM, Lowy DR, Schiller JT: Papillomaviruses infect cells via a clathrin-dependent pathway. Virology 307(1), 1-11 (2003).
11. Ustay M, Stenlund A. Transient replication of BPV-1 requires two viral polypeptide, encoded by the E1 and E2 open reading frames. Embo J. 10(2), 4419-457 (1991).
12. Chiang CM, Ustav M, Stenlund A et al.: Viral E1 ind E2 proteins support replication of homologous and heterològous papillomaviral origins. Proc. Natl Acad. Sci. USA 89(13), 5799-5803 (1992).
13. Yang L, Li P, Mohr IJ, Clark R, otchan MR: Activation of BPV-1 replication in vitro by the transcription factor E2. Nature 353(6345), 628-632 (1991).
14. Sedman J, Stenlund A: Cooperative interaction between the initiator E1 and the transcriptional activator E2 is required for replicator specific DNA replication of bovine papillomavirus in vivo and in vitro. Embo J. 14(24),6218-6228 (1995).
15. Yang L, Mohr I, Fouts E et al.: The E1 protein of bovine papilloma virus 1 is an ATP-dependent DNA helicase. Proc. Natl Acad. Sci. USA 90(11), 5086-5090 (1993).
16. Seo, YS, Muller F, Lusky M, Hurwitz J: Bovine papilloma virus (BPV)-encoded E1 protein contains multiple activities required for BPV DNA replication. Proc. Natl Acad. Sci. USA 90(2), 702-706 (1993).
17. Sedman J, Stenlund A: The papillómavirus E1 protein forms a DNA-dependent, hexameric complex with ATPase and DNA helicase activities. J. Virol. 72(8), 6893-6897(1998).
18. Sedman J, Stenlund A: The initiator protein E1 binds to the bovine papillomavirus origin of replication as a trimeric ring-like structure. Embo J. 15(18), 5085-5092 (1996).
19. Stenlund A. E1 initiator DNA binding specificity is unmasked by selective inhibition of nonspecific DNA binding. Embo J. 22(4), 954-963 (2003).
20. Mohr IJ, Clark R, Sun S et al.: Targeting the E1 replication protein to die papillomavirus origin of replication by complex formation with the E2 transactivator. Science 250(4988), 1694-1699 (1990).
21. Seo YS, Muller F, Lusky M et al.: Bovine papilloma virus (BPV)-encoded E2 protein enhances binding of E1 protein to the BPV replication origin. Proc. Natl Acad Sci. USA 90(7), 2865-2869 (1993).
22. Sedman T, Sedman J, Stenlund A. Binding of the E1 and E2 proteins to the origin of replication of bovine papillomavirus. J. Virol. 71(4),2887-2896 (1997).
23. Hawley-Nelson P, Androphy EJ, Lowy DR, Schiller JT: The specific DNA recognition sequence of the bovine papillomavirus E2 protein is an E2-dependent enhancer. Embo J. 7(2), 525-531 (1988).
24. Hirochika. H, Hirochika R, Broker TR. Chow LT: Functional mapping of the human papillomavinis type 11 transcriptional enhancer and its interaction with the trans-acting E2 proteins. Genes Dev. 2(1), 54-67 (1988).
25. McBride AA, Schlegel R, Howley PM: The carboxy-terminal domain shared by the bovine papillomavirus E2 transactivator and repressor proteins contains a specific DNA, binding activity. Embo J. 7(2), 533-539 (1988).
26. Li R. Knight J, Bream G, Stenlund A, Botchan M: Specific recognition nucleotides and their DNA context determine the affinity of E2 protein for 17 binding sites in the BPV-1 genome. Genes Dev. 3(4), 510-526 (1989).
27. Lusky M, Hurwitz J, Seo YS: Cooperative assembly of the bovine papilloma virus E1 and E2 proteins on the replication origin requires an intact E2 binding site. J. Biol. Chem. 268(21), 15795-15803 (1993).
28. Lusky M, Hurwitz J, Seo YS: The bovine papillomavirus E2 protein modulates the assembly of but is not stably maintained in a replication-competent multimeric El-replication origin complex. Proc. Natl Acad. Sci. USA 91(19), 8895-8899 (1994).
29. Schuck S, Stenlund A: Assembly of a double hexameric helicase. Mol. Cell. 20(3), 377-389 (2005).
30. Schuck S, Stenlund A: ATP-dependent minor groove recognition of TA base pairs is required for template melting by the E1 initiator protein. J. Virol. 81(7), 3293-3302 (2007).
31. Enemark EJ, Stenlund A, Joshua-Tor L: Crystal structures of two intermediates in the assembly of the papillomavirus replication initiation complex. Embo J. 21(6), 1487-1496 (2002).
32. Sanders CM, Stenlund A: Recruitment and loading of the E1 initiator protein: an ATP-dependent process catalysed by a transcription factor. Embo J. 17(23), 7044-7055 (1998).
33. Lin BY, Makhov AM, Griffith JD, Broker TR, Chow LT: Chaperone proteins abrogate inhibition of the human papillomavirus (HPV) E1 replicative helicase by the HPV E2 protein. Mol. Cell. Biol 22(18), 6592-6694 (2002).
34. Han Y, Loo YM, Militello KT, Melendy T: Interactions of the papovavirus DNA replication initiator proteins, bovine papillomavirus type 1 E1 and simian virus 40 large T antigen, with human replication protein A. J. Virol. 73(6), 4899-4907 (1999).
35. Loo YM, Melendy T: Recruitment of replication protein A by the papillomavirus E1 protein and modulation by single-stranded DNA. J. Virol. 78(4), 1605-1615 (2004).
36. Hu Y, Clower RV, Melendy T: Cellular topoisomerase I modulates origin binding by bovine papillomavirus type 1 E1. J. Virol. 80(9), 4363-4371 (2006).
37. Clower RV, Fisk JC, Melendy T: Papillomavirus E1 protein binds to and stimulates human topoisomerase I. J. Virol. 80(3), 1584-1587 (2006).
38. Bonne-Andrea C, Santucci S, Clertant P, Tillier F: Bovine papillomavirus E1 protein binds specifically DNA polymerase alpha but not replication protein A. J. Virol. 69(4), 2341-2350 (1995).
39. Park P, Copeland W, Yang L et al.: The cellular DNA polymerase alpha-primase is required for papillomavirus DNA replication and associates with the viral E1 helicase. Proc. Natl Acad. Sci. USA 91(18), 8700-8704 (1994).
40. Masterson PJ, Stanley MA, Lewis AP, Romanos MA: A C-terminal helicase domain of the human papillomavirus E1 protein binds E2 and the DNA polymerase alpha-primase p68 subunit. J. Virol. 72(9), 7407-7419 (1998).
41. Clower RV, Hu Y, Melendy T: Papillomavirus E2 protein interacts with and stimulates human topoisomerase I. Virology 348(1), 13-18 (2006).
42. Donaldson MM, Boner W, Morgan IM: TopBP1 regulates human papillomavirus type 16 E2 interaction with chromatin. J. Virol. 81(8), 4338-4342 (2007).
43. Thain A, Jenkins O, Clarke AR, Gaston K: CpG methylation directly inhibits binding of the human papillomavirus type 16 E2 protein to specific DNA sequences. J. Virol. 70(10), 7233-7235 (1996).
44. Bhattacharjee B, Sengupta S: CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2. Virology 354(2), 280-285 (2006).
45. Badal S, Badal V, Calleja-Macias IE et al.: The human papillomavirus-18 genome is efficiently targeted by cellular DNA methylation. Virology 324(2), 483-492 (2004).
46. Fields BN, Knipe D, Howley PM: Fields Virology (3rd edition). Lippencort-Raven Publishers, Philadelphia, PA, USA (1996)
47. Gilbert DM, Cohen SN: Bovine papilloma virus plasmids replicate randomly in mouse fibroblasts throughout S phase of the cell cycle. Cell 50(1), 59-68 (1987).
48. Botchan M, Berg L, Reynolds J, Lusky M: The BPV1 replication. John Wiley and Sons, Bath, UK (1986).
49. Ravnan JB, Gilbert DM, Ten Hagen KG, Cohen SN: Random-choice replication of extrachromosomal bovine papillomavirus (BPV) molecules in heterogeneous, clonally derived BPV-infircted cell lines. J. Virol. 66(12), 6946-6952 (1992).
50. Hoffmann R, Hirt B, Bechtold V, Beard P, Raj K: Different modes of human papillomavirus DNA replication during maintenance. J. Virol. 80(9), 4431-4439 (2006).
51. Thomas JT, Hubert WG, Ruesch MN, Laimins LA: Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes. Proc. Natl Acad. Sci. USA 96(15), 8449-8454 (1999).
52. Park RB, Androphy EJ: Genetic analysis of high-risk E6 in episomal maintenance of human papillomavirus genomes in primary human keratinocytes. J. Virol. 76(22), 11359-11364 (2002).
53. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM: The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63(6), 1129-1136 (1990).
54. Lepik D, Ilves I, Kristjuhan A, Maimets T, Ustav M: p53 protein is a suppressor of papillomavirus DNA amplificational replication. J. Virol. 72(8), 6822-6831 (1998).
55. Ilves I, Kadaja M, Ustav M: Two separate replication modes of the bovine papillomavirus BPV1 origin of replication that have different sensitivity to p53. Virus Res. 96(1-2), 75-84 (2003).
56. Parish JL, Kowalczyk A, Chen HT et al.: E2 proteins from high- and low-risk human papillomavirus types differ in their ability to bind p53 and induce apoptotic cell death. J. Virol. 80(9), 4580-4590 (2006).
57. Massimi P, Pim D, Bertoli C, Bouvard V, Banks L: Interaction between the HPV-16 E2 transcriptional activator and p53. Oncogene 18(54), 7748-7754 (1999).
58. Flores ER, Allen-Hoffmann BL, Lee D, Lambert PF: The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle. J. Virol. 74(14), 6622-6631 (2000).
59. Kim K, Lambert PF: E1 protein of bovine papillomavirus 1 is not required for the maintenance of viral plasmid DNA replication. Virology 293(1), 10-14 (2002).
60. Ritzi M, Tillack K, Gerhardt J et al.: Complex protein-DNA dynamics at the latent origin of DNA replication of Epstein-Barr virus. J. Cell Sci. 116(Pt 19), 3971-3984 (2003).
61. Hirai K, Shirakata M: Replication licensing of the EBV oriP minichromosome. Curr. Top. Microbiol. Immunol. 258, 13-33 (2001).
62. Chaudhuri B, Xu H, Todorov I, Dutta A, Yates JL: Human DNA replication initiation factors, ORC and MCM, associate with oriP of Epstein-Barr virus. Proc. Natl Acad. Sci. USA 98(18),1 0085-10089 (2001).
63. Voitenleitner C, Botchan M: E1 protein of bovine papillomavirus type 1 interferes with E2 protein-mediated tethering of the viral DNA to mitotic chromosomes. J. Virol. 76(7), 3440-3451 (2002).
64. Stubenrauch F, Hummel M, Iftner T, Laimins LA: The E8E2C protein, a negative regulator of viral transcription and replication, is required for extrachromosomal maintenance of human papillomavirus type 31 in keratinocytes. J. Virol. 74(3), 1178-1186 (2000).
65. McBride AA, Oliveira JG, McPhillips MG: Partitioning viral genomes in mitosis: same idea, different targets. Cell Cycle 5(14), 1499-1502 (2006).
66. Dao LD, Duffy A, Van Tine BA et al.: Dynamic localization of the human papillomavirus type 11 origin binding protein E2 through mitosis while in association with the spindle apparatus. J. Virol. 80(10), 4792-4800 (2006).
67. Yu T, Peng YC, Androphy EJ: Mitotic kinesin-like protein 2 binds and colocalizes with papillomavirus E2 during mitosis. J. Virol. 81(4), 1736-1745 (2007).
68. Parish JL, Bean AM, Park RB, Androphy EJ: ChlR1 is required for loading papillomavirus E2 onto mitotic chromosomes and viral genome maintenance. Mol, Cell. 24(6), 867-876 (2006).
69. Ozbun MA, Meyers C: Temporal usage of multiple promoters during the life cycle of human papillomavirus type 31b. J. Virol. 72(4), 2715-2722 (1998).
70. Hummel M, Hudson JB, Laimins LA: Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes. J. Virol. 66, 6070-6080 (1992).
71. Hummel M, Lim HB, Laimins LA: Human papillomavirus type-31b late gene expression is regulated through protein kinase C-mediated changes in RNA processing. J. Virol. 69, 3381-3388 (1995).
72. Grassman K, Rapp B, Maschek H, Petry KU, Iftner T: Idenfication of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNA. J. Virol. 70, 2339-2349 (1996).
73. Zheng ZM, Baker CC: Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci. 11, 2286-2302 (2006).
74. Klumpp DJ, Laimins LA: Differentiation-induced changes in promoter usage for transcripts encoding the human papillomavirus type 31 replication protein E1. Virology 257(1), 239-246 (1999).
75. Raj K, Bechtold V: Regulation of human papillomavirus gene expression. In: Recent Research and Development in Virology. Pandalai SG (Ed.) Transworld Research Network, Kerela, India 273-303 (2004).
76. Lentz MR, Pak D, Mohr I, Botchan MR. The E1 replication protein of bovine papillomavirus type 1 contains an extended nuclear localization signal that includes a p34cdc2 phosphorylation site. J. Virol. 67(3), 1414-1423 (1993).
77. Yu JH, Lin BY, Deng W, Broker TR, Chow LT: Mitogen-activated protein kinases activate the nuclear localization sequence of human papillomavirus type 11 E1 DNA helicase to promote efficient nuclear import. J. Virol. 81(10), 5066-5078 (2007).
78. Deng W, Lin BY, Jin G et al.: Cyclin/CDK regulates the nucleocytoplasmic localization of the human papillomavirus E1 DNA helicase. J. Virol. 78(24), 13954-13965 (2004).
79. Ma T, Zou N, Lin BY, Chow LT, Harper JW: Interaction between cyclin-dependent kinases and human papillomavirus replication-initiation protein E1 is required for efficient viral replication. Proc. Natl Acad. Sci. USA 96(2), 382-387 (1999).
80. Hsu CY, Mechali F, Bonne-Andrea C: Nucleocytoplasmic shuttling of bovine papillomavirus E1 helicase downregulates viral DNA replication in S phase. J. Virol. 81(1), 384-394 (2007).
81. Malcles MH, Cueille N, Mechali F, Coux O, Bonne-Andrea C: Regulation of bovine papillomavirus replicative helicase E1 by the ubiquitin-proteasome pathway. J. Virol. 76(22), 11350-11358 (2002).
82. Munger K, Werness BA, Dyson N et al.: Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. Embo J. 8(13), 4099-4105 (1989).
83. Scheffner M, Munger K, Byrne JC, Howley PM: The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl Acad. Sci. USA 88(13), 5523-5527 (1991).
84. Mantovani F, Banks L: The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20(54), 7874-7887 (2001).
85. Dostatni N, Lambert PF, Sousa R et al.: The functional BPV-1 E2 transactivating protein can act as a repressor by preventing formation of the initiation complex. Genes Dev. 5(9), 1657-1671 (1991).
86. Desaintes C, Demeret C, Goyat S, Yaniv M, Thierry F: Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis. Embo J. 16(3), 504-514 (1997).
87. Narechania A, Terai M, Chen Z, DeSalle R, Burk RD: Lack of the canonical pRB-binding domain in the E7 ORF of artiodactyl papillomaviruses is associated with the development of fibropapillomas. J. Gen. Virol. 85(Pt 5), 1243-1250 (2004).
88. Bechtold V, Beard P, Raj K: Human papillomavirus type 16 E2 protein has no effect on transcription from episomal viral DNA. J. Virol. 77(3), 2021-2028 (2003).
89. Peh WL, Brandsma JL, Christensen ND et al.: The viral E4 protein is required for the completion of the cottontail rabbit papillomavirus productive cycle in vivo. J. Virol. 78(4), 2142-2151 (2004).
90. Nakahara T, Peh WL, Doorbar J, Lee D, Lambert PF: Human papillomavirus type 16 E1∧E4 contributes to multiple facets of the papillomavirus life cycle. J. Virol. 79(20), 13150-13165 (2005).
91. Wilson R, Fehrmann F, Laimins LA: Role of the E1-E4 protein in the differentiation-dependent life cycle of human papillomavirus type 31. J. Virol. 79(11), 6732-6740 (2005).
92. Wilson R, Ryan GB, Knight GL, Laimins LA, Roberts S: The full-length E1-E4 protein of human papillomavirus type 18 modulates differentiation-dependent viral DNA amplification and late gene expression. Virology 362(2), 453-460 (2007).
93. Genther SM, Sterling S, Duensing S et al.: Quantitative role of the human papillomavirus type 16 E5 gene during the productive stage of the viral life cycle. J. Virol. 77(5), 2832-2842 (2003).
94. Fehrmann F, Klumpp DJ, Laimins LA: Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation. J. Virol. 77(5), 2819-2831 (2003).
95. DeMasi J, Huh KW, Nakatani Y, Munger K, Howley PM: Bovine papillomavirus E7 transformation function correlates with cellular p600 protein binding. Proc. Natl Acad. Sci. USA 102(32), 11486-11491 (2005).
96. Huh KW, DeMasi J, Ogawa H et al.: Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600. Proc. Natl Acad. Sci. USA 102(32), 11492-11497 (2005).
97. Flores ER, Lambert PF: Evidence for a switch in the mode of human papillomavirus type 16 DNA replication during the viral life cycle. J. Virol. 71(10), 7167-7179 (1997).
98. Schwartz S: Regulation of human papillomavirus late gene expression. Ups. J. Med. Sci. 105(3), 171-192 (2000).
99. Zhou J, Liu WJ, Peng SW, Sun XY, Frazer I: Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability. J. Virol. 73(6), 4972-4982 (1999).
100. Zhao KN, Liu WJ, Frazer IH: Codon usage bias and A+T content variation in human papillomavirus genomes. Virus Res. 98(2), 95-104 (2003).
101. Day PM, Roden RBS, Lowy DR, Schiller JT: The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains. J. Virol. 72(1), 142-150 (1998).
102. Zhao KN, Hengst K, Liu WJ et al.: BPV1 E2 protein enhances packaging of full-length plasmid DNA in BPV1 pseudovirions. Virology 272(2), 382-393 (2000).
103. Florin L, Sapp C, Streeck RE, Sapp M: Assembly and translocation of papillomavirus capsid proteins. J. Virol. 76(19), 10009-10014 (2002).
104. Holmgroh SC, Patterson NA, Ozbun MA, Lambert PF: The minor capsid protein L2 contributes to two steps in the human papillomavirus type 31 life cycle. J. Virol. 79(7), 3938-3948 (2005).
105. Finnen RL, Erickson KD, Chen XS, Garcea RL: Interactions between papillomavirus L1 and L2 capsid proteins. J. Virol. 77(8), 4818-4826 (2003).
106. Egawa K, Iftner A, Doorbar J, Honda Y, Iftner T: Synthesis of viral DNA and late capsid protein L1 in parabasal spinous cell layers of naturally occurring benign warts infected with human papillomavirus type 1. Virology 268(2), 281-293 (2000).
107. Doorbar J, Foo C, Coleman N et al.: Characterization of events during the late stages of HPV16 infection in vivo using high-affinity synthetic Fabs to E4. Virology 238(1), 40-52 (1997).
108. Nicholls P, Doorbar J, Moore RW et al.: Detection of viral DNA and E4 protein in basal keratinocytes of experimental canine oral papillomavirus lesions. Virology 283, 82-98 (2001).
109. Pfister H: Chapter 8: Human papillomavirus and skin cancer. J. Natl Cancer Inst. Monogr. (31), 52-56 (2003).
110. Antonsson A, Karanfilovska S, Lindqvist PG, Hansson BG: General acquisition of human papillomavirus infections of skin occurs in early infancy. J. Clin. Microbiol. 41(6), 2509-2514 (2003).